000			03006nam a22004815i 4500
001			978-90-481-8618-1
003			DE-He213
005			20140220084601.0
007			cr nn 008mamaa
008			100721s2010 ne | s |||| 0|eng d
020			_a9789048186181 _9978-90-481-8618-1
024	7		_a10.1007/978-90-481-8618-1 _2doi
050		4	_aRC261-271
072		7	_aMJCL _2bicssc
072		7	_aMED062000 _2bisacsh
082	0	4	_a614.5999 _223
100	1		_aNewman, William G. _eeditor.
245	1	0	_aPharmacogenetics: Making cancer treatment safer and more effective _h[electronic resource] / _cedited by William G. Newman.
264		1	_aDordrecht : _bSpringer Netherlands : _bImprint: Springer, _c2010.
300			_aVI, 245p. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
505	0		_aPrinciples of Cancer Treatment -- Clinical Pharmacology and Anticancer Drugs -- Principles of Genetics and Pharmacogenetics -- Pharmacogenetics in the Management of Breast Cancer -- Pharmacogenetics in Colorectal Cancer -- Pharmacogenetics in Lung Cancer -- Pharmacogenetics and Cancer Treatment in Children -- Pharmacogenetics in Palliative Care -- Genetic Predictors of Normal Tissue Response to Radiotherapy -- Cancer Pharmacogenetics in Industry -- Ethical Issues in Pharmacogenetics -- Economics of Cancer Pharmacogenetics -- Future Advances in Cancer Pharmacogenomics.
520			_aChemotherapy has made a dramatic difference to improved survival in patients with cancer. However, not all patients respond and some experience serious side effects. "Pharmacogenetics: Making cancer treatment safer and more effective" is an up to date summary of the exciting new field of how genetic testing can tailor more effective prescription in oncology. It is targeted at oncologists and professionals involved in the treatment of patients with cancer. It provides a core background in genetics and pharmacological principles before providing chapters from acknowledged experts in the field on genetic tests in specific cancer types, including breast, bowel and lung cancer. Clinical cases are used to illustrate the practical application of this knowledge. Chapters on ethics, health economics and the industry aspects of pharmacogenetics set out the challenges and opportunities afforded by this new science.
650		0	_aMedicine.
650		0	_aOncology.
650		0	_aHuman genetics.
650		0	_aToxicology.
650	1	4	_aBiomedicine.
650	2	4	_aCancer Research.
650	2	4	_aPharmacology/Toxicology.
650	2	4	_aHuman Genetics.
650	2	4	_aOncology.
650	2	4	_aBiomedicine general.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9789048186174
856	4	0	_uhttp://dx.doi.org/10.1007/978-90-481-8618-1
912			_aZDB-2-SBL
999			_c113503 _d113503